| review article | Q7318358 |
| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| P2093 | author name string | Xiao J | |
| Ho KM | |||
| Litton E | |||
| P2860 | cites work | II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults | Q83296279 |
| Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study | Q83578318 | ||
| Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery | Q84514800 | ||
| Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia | Q84597168 | ||
| Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy | Q84871240 | ||
| Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice | Q21134027 | ||
| Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data | Q21261840 | ||
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 | ||
| Efficacy and safety of epoetin alfa in critically ill patients | Q28246281 | ||
| Iron overload in human disease | Q28258134 | ||
| A randomized controlled study of iron supplementation in patients treated with erythropoietin | Q28296498 | ||
| Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. | Q31781928 | ||
| Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data | Q33270075 | ||
| Review of issues relating to iron and infection | Q33749256 | ||
| A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial | Q34010689 | ||
| Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial | Q34014222 | ||
| Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia | Q34662889 | ||
| A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients | Q34885195 | ||
| Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study | Q35584219 | ||
| Iron deficiency anemia in pregnancy: intravenous versus oral route | Q36240403 | ||
| The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial | Q36408762 | ||
| Iron sucrose versus oral iron therapy in pregnancy anemia. | Q36490999 | ||
| Ferumoxytol for treating iron deficiency anemia in CKD | Q36796801 | ||
| Risk of infection with intravenous iron therapy | Q36897822 | ||
| Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis | Q36946004 | ||
| Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients | Q37087894 | ||
| Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature | Q37234940 | ||
| Ferric carboxymaltose: a review of its use in iron-deficiency anaemia | Q37465214 | ||
| Can intravenous iron therapy meet the unmet needs created by the new restrictions on erythropoietic stimulating agents? | Q37634122 | ||
| Detection, evaluation, and management of iron-restricted erythropoiesis | Q37786455 | ||
| Adverse blood transfusion outcomes: establishing causation | Q37846315 | ||
| New erythropoiesis-stimulating agents and new iron formulations | Q37882316 | ||
| Strategies to preempt and reduce the use of blood products: an Australian perspective | Q37966874 | ||
| Iron deficiency syndromes and iron-restricted erythropoiesis (CME). | Q37972641 | ||
| Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials | Q38033247 | ||
| A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia | Q38314781 | ||
| The effect of parenteral iron administration on the development of Staphylococcus aureus-induced experimental pyelonephritis in rats | Q41165771 | ||
| Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients | Q42632726 | ||
| Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy | Q43201885 | ||
| Ferric carboxymaltose in patients with heart failure and iron deficiency | Q43240282 | ||
| Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial | Q43244187 | ||
| Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial | Q43291667 | ||
| Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial | Q43491824 | ||
| A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. | Q43832681 | ||
| Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route | Q43924203 | ||
| [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study]. | Q45945974 | ||
| Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study | Q46068464 | ||
| A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia | Q46416725 | ||
| Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. | Q46430341 | ||
| Post-haemodilution anaemia in paediatric cardiac surgery: benefit of intravenous iron therapy | Q46591858 | ||
| Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. | Q46674533 | ||
| Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. | Q46708773 | ||
| Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia | Q46782839 | ||
| Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia | Q46796463 | ||
| Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial | Q46810797 | ||
| Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. | Q46826565 | ||
| Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency | Q46940287 | ||
| Intravenous Iron Administration to Very‐Low‐Birth‐Weight Newborns Receiving Total and Partial Parenteral Nutrition | Q47359055 | ||
| Iron therapy in the pediatric hemodialysis population | Q47816838 | ||
| Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial | Q47856811 | ||
| A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome | Q47888000 | ||
| Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial | Q48279773 | ||
| A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome | Q48398969 | ||
| Intravenous versus oral iron therapy for postpartum anaemia | Q48659950 | ||
| Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia | Q48739235 | ||
| IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. | Q48955860 | ||
| Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial | Q49166237 | ||
| Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. | Q50569936 | ||
| Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. | Q50570321 | ||
| Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. | Q50705457 | ||
| Intravenous iron following cardiac surgery does not increase the infection rate. | Q50721093 | ||
| Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*. | Q50946825 | ||
| Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. | Q51028527 | ||
| High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron. | Q51555478 | ||
| A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. | Q52862847 | ||
| Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. | Q53151013 | ||
| Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. | Q53980523 | ||
| A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease | Q54989527 | ||
| Iron prophylaxis in pregnancy: intravenous route versus oral route | Q56781985 | ||
| Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study | Q61371441 | ||
| Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease | Q61908010 | ||
| Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease-A Randomized, Controlled, Open-Label, Multicenter Study | Q61908107 | ||
| A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin | Q71422638 | ||
| [Effectiveness of oral versus parenteral iron substitution in autologous blood donors] | Q72779468 | ||
| Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin | Q73340547 | ||
| A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy | Q74330321 | ||
| Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation | Q77113133 | ||
| Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study | Q77770234 | ||
| Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy | Q79595523 | ||
| Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study | Q79657062 | ||
| Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial | Q80710282 | ||
| Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial | Q80796974 | ||
| Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia | Q80980169 | ||
| A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD | Q81549416 | ||
| Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial | Q81555500 | ||
| Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis | Q81639422 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P433 | issue | aug15 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood transfusion | Q183605 |
| inorganic compound | Q190065 | ||
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | f4822 | |
| P577 | publication date | 2013-08-15 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials | |
| P478 | volume | 347 |
| Q39087951 | A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients |
| Q51197806 | A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors. |
| Q58001487 | Anaemia; a contraindication to elective surgery for colorectal cancer? |
| Q54939969 | Anemia and acute coronary syndrome: current perspectives. |
| Q90720906 | Anemia of Inflammation with An Emphasis on Chronic Kidney Disease |
| Q38234242 | Anemia of inflammation |
| Q57172457 | Association of iron status with the risk of bloodstream infections: results from the prospective population-based HUNT Study in Norway |
| Q39258133 | Clinical practice guidelines on iron therapy: A critical evaluation |
| Q39331265 | Considerations and controversies in managing chronic kidney disease: An update |
| Q48787043 | Correction of iron deficiency anaemia using IV CosmoFer in CKD patients with asthma: a prospective study. |
| Q41547046 | Current misconceptions in diagnosis and management of iron deficiency |
| Q89533636 | Diagnosis and management of iron deficiency in children with or without anemia: consensus recommendations of the SPOG Pediatric Hematology Working Group |
| Q38188501 | Diagnosis and treatment of cancer-related anemia. |
| Q48092481 | Diagnostic approach to iron deficiency anemia |
| Q35942721 | ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage |
| Q47719745 | Effect of Intravenous Iron Supplementation on Hepcidin Levels in Iron Deficient Pregnant Females in Second and Third Trimester |
| Q50266795 | Effect of intravenous iron on outcomes of acute kidney injury |
| Q35474305 | Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. |
| Q64066050 | Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: A systematic review and meta-analysis |
| Q92218228 | Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial |
| Q38910522 | Evaluating appropriate red blood cell transfusions: a quality audit at 10 Ontario hospitals to determine the optimal measure for assessing appropriateness |
| Q43814110 | Exacerbation of myasthenia symptoms following intravenous iron administration. |
| Q47745978 | Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial |
| Q38271890 | Ferric carboxymaltose: a review of its use in iron deficiency |
| Q92031701 | Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis |
| Q50216122 | Haemoglobin responses to transfusion in severe iron deficiency anaemia: potential impact of gastrointestinal disorders |
| Q58755798 | Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study |
| Q41012196 | Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region. |
| Q58700150 | Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease |
| Q36673495 | Impact of a Patient Blood Management Program and an Outpatient Anemia Management Protocol on Red Cell Transfusions in Oncology Inpatients and Outpatients |
| Q53642889 | Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study. |
| Q36073896 | Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation |
| Q57167424 | Intravenous Irons: From Basic Science to Clinical Practice |
| Q53651129 | Intravenous iron administration: new observations and time for the next steps. |
| Q34455198 | Intravenous iron exposure and mortality in patients on hemodialysis |
| Q42975965 | Intravenous iron exposure and outcomes in patients on hemodialysis |
| Q50226676 | Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness. |
| Q89351440 | Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil |
| Q47150240 | Intravenous iron vs blood for acute post-partum anaemia (IIBAPPA): a prospective randomised trial |
| Q48109625 | Intravenous iron: barriers and facilitators to its use at nine maternity hospitals in New South Wales, Australia. |
| Q98178909 | Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk |
| Q38826753 | Iron Loading Exaggerates the Inflammatory Response to the Toll-like Receptor 4 Ligand Lipopolysaccharide by Altering Mitochondrial Homeostasis. |
| Q64111473 | Iron Metabolism: An Emerging Therapeutic Target in Critical Illness |
| Q38575172 | Iron deficiency anaemia |
| Q46308433 | Iron deficiency anaemia in pregnancy: The role of parenteral iron |
| Q39000612 | Iron deficiency anemia in the emergency department: over-utilization of red blood cell transfusion and infrequent use of iron supplementation |
| Q38245887 | Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. |
| Q34612274 | Iron supplementation and mortality in incident dialysis patients: an observational study. |
| Q37295004 | Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis |
| Q96018638 | Is the Italian consent to transfusion really informed? A medico-legal analysis between old ghosts and new evidence |
| Q35659768 | Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review |
| Q38928171 | Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach. |
| Q90263861 | Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent |
| Q55184664 | Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide. |
| Q24194924 | Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors |
| Q40155473 | Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia |
| Q33690856 | Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland |
| Q38575053 | Patient blood management to reduce surgical risk |
| Q47285951 | Peri-operative correction of non-anaemic iron deficiency |
| Q48504728 | Perioperative Blood Management Strategies for Total Knee Arthroplasty |
| Q35203534 | Population pharmacokinetic meta-analysis to bridge ferumoxytol plasma pharmacokinetics across populations. |
| Q47225343 | Postoperative outcomes following cardiac surgery in non-anaemic iron-replete and iron-deficient patients - an exploratory study. |
| Q26998362 | Pre-operative anaemia |
| Q48225857 | Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease |
| Q26771408 | Reducing transfusion requirements in liver transplantation |
| Q36551429 | Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity |
| Q40280114 | Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity |
| Q92546948 | Risk of infection associated with intravenous iron preparations: protocol for updating a systematic review |
| Q35220772 | Role of intravenous iron sucrose in correction of anemia in antenatal women with advanced pregnancy |
| Q47969249 | Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review |
| Q26764881 | Safety concerns about intravenous iron therapy in patients with chronic kidney disease |
| Q49791535 | Safety of Intravenous Iron in Dialysis: A Systematic Review and Meta-Analysis |
| Q26853397 | Safety of intravenous iron formulations: facts and folklore |
| Q30234981 | Safety of intravenous iron in hemodialysis patients |
| Q37320585 | Safety of intravenous iron use in chronic kidney disease. |
| Q26781155 | Screening for iron deficiency and iron deficiency anaemia in pregnancy: a structured review and gap analysis against UK national screening criteria |
| Q55347421 | Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients. |
| Q38819226 | Systematic review and meta-analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review |
| Q38341331 | Systematic review and meta-analysis: what is the evidence for oral iron supplementation in treating anaemia in elderly people? |
| Q35849765 | The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry |
| Q50216213 | The Effect of Preoperative Anemia on the Outcome After Coronary Surgery |
| Q27339343 | The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition |
| Q48548255 | The safety of available treatment options for iron-deficiency anemia |
| Q50203102 | Transfusion in elderly: Take account frailty |
| Q42214747 | Transfusion of stored blood impairs host defenses against Gram-negative pathogens in mice |
| Q31056026 | Transfusion practices and infectious risks |
| Q48040293 | What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: Emerging Evidence on the Safety of Intravenous Iron in Chronic Kidney Disease |
| Q86033804 | [Algorithm for treating preoperative anemia] |
Search more.